RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF TWO DIFFERENT DOSES OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) FOR THE TREATMENT OF CIDP: IGG DEPENDENCY AND RESTABILIZATION PHASE

Author(s):
Schaik, I.N. van; Bril, V.; Geloven, N. van; Hartung, H.P.; Lewis, R.A.; Sobue, G.; Durn, B.; Lawo, J.P.; Mielke, O.; Cornblath, D.R.; Merkies, I.S.J.; PATH Study Grp
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-09-30
Language
English
Is part of
Journal of the Peripheral Nervous System (2016), Vol. 21, no. 3, p. 221-221
hdl
1887/113016